Tirzepatide is a dual GIP and GLP-1 receptor agonist approved by the FDA for type 2 diabetes and chronic weight management
A meta-analysis of 113 RCTs comprising 33,167 patients in the GLP-1 RA cohort and 26,683 in the comparator cohort revealed no significant elevation in pancreatitis or pancreatic cancer risk relative to control groups (Mantel-Haenszel odds ratio [MH-OR] of 0.93 and 0.94, respectively), but identified a notable increase in cholelithiasis risk (MH-OR, 1.30) [58]
Breastfeeding mothers often experience hormonal fluctuations, particularly changes in prolactin and oxytocin, that influence appetite regulation and fat storage differently than in non-lactating women
At Peptides Thailand, retatrutide is offered only under physician supervision with clinical-grade, verifiable sourcing and Certificates of Analysis on every batch
Note that Ozempic was first developed in 2012 and has only been available in the U.S
How does it do this